Your browser doesn't support javascript.
loading
Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity.
Eakins, Rachel A; Chobrutskiy, Andrea; Teer, Jamie K; Patel, Dhruv N; Hsiang, Monica; Huda, Taha I; Zaman, Saif; Sexton, Wade J; Coppola, Domenico; Falasiri, Shayan; Blanck, George; Chobrutskiy, Boris I.
Afiliación
  • Eakins RA; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida 33612, USA.
  • Chobrutskiy A; Department of Pediatrics, Oregon Health and Science University Hospital, Portland, OR 97239, USA.
  • Teer JK; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Patel DN; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida 33612, USA.
  • Hsiang M; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida 33612, USA.
  • Huda TI; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida 33612, USA.
  • Zaman S; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida 33612, USA.
  • Sexton WJ; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Coppola D; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Falasiri S; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida 33612, USA.
  • Blanck G; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida 33612, USA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. Electronic address: gblanck@usf.edu.
  • Chobrutskiy BI; Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, OR 97239, USA.
Mol Immunol ; 150: 58-66, 2022 10.
Article en En | MEDLINE | ID: mdl-35987136

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas / Receptores de Antígenos de Linfocitos T / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Mol Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas / Receptores de Antígenos de Linfocitos T / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Mol Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos